Cosmo Pharmaceuticals N.V. (COPN.SW)
CHF 48.35
(1.47%)
CHF 48.35
(1.47%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -48.43 Million EUR | -296.14% |
| 2022 | -12.22 Million EUR | 57.31% |
| 2021 | -28.64 Million EUR | -60.98% |
| 2020 | -17.79 Million EUR | -132.68% |
| 2019 | 54.45 Million EUR | 203.64% |
| 2018 | -52.53 Million EUR | 62.6% |
| 2017 | -140.46 Million EUR | -25.04% |
| 2016 | -112.34 Million EUR | -77.91% |
| 2015 | -63.14 Million EUR | -172.07% |
| 2014 | -23.2 Million EUR | 32.91% |
| 2013 | -34.59 Million EUR | -139.13% |
| 2012 | -14.46 Million EUR | -26.35% |
| 2011 | -11.44 Million EUR | 53.94% |
| 2010 | -24.85 Million EUR | -75.21% |
| 2009 | -14.18 Million EUR | 20.63% |
| 2008 | -17.87 Million EUR | 25.42% |
| 2007 | -23.96 Million EUR | -416.33% |
| 2006 | 7.57 Million EUR | -63.71% |
| 2005 | 20.87 Million EUR | 9.48% |
| 2004 | 19.06 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -53.7 Million EUR | -10.88% |
| 2024 Q2 | -53.1 Million EUR | 1.12% |
| 2023 Q3 | -49.19 Million EUR | -186.56% |
| 2023 Q4 | -48.43 Million EUR | 1.54% |
| 2023 Q1 | 56.05 Million EUR | 558.41% |
| 2023 Q2 | 56.83 Million EUR | 1.4% |
| 2023 FY | -48.43 Million EUR | -296.14% |
| 2022 Q2 | -46.2 Million EUR | 1.66% |
| 2022 Q3 | -12.98 Million EUR | 71.9% |
| 2022 FY | -12.22 Million EUR | 57.31% |
| 2022 Q4 | -12.22 Million EUR | 5.82% |
| 2022 Q1 | -46.98 Million EUR | -64.03% |
| 2021 FY | -28.64 Million EUR | -60.98% |
| 2021 Q2 | -12.29 Million EUR | 8.04% |
| 2021 Q3 | -29.39 Million EUR | -139.19% |
| 2021 Q4 | -28.64 Million EUR | 2.57% |
| 2021 Q1 | -13.36 Million EUR | 24.88% |
| 2020 Q3 | -20.59 Million EUR | -124.11% |
| 2020 Q2 | 85.42 Million EUR | 3.49% |
| 2020 Q4 | -17.79 Million EUR | 13.62% |
| 2020 Q1 | 82.54 Million EUR | 51.6% |
| 2020 FY | -17.79 Million EUR | -132.68% |
| 2019 Q4 | 54.45 Million EUR | 2.59% |
| 2019 FY | 54.45 Million EUR | 203.64% |
| 2019 Q2 | 5.26 Million EUR | 37.1% |
| 2019 Q3 | 53.07 Million EUR | 907.92% |
| 2019 Q1 | 3.84 Million EUR | 107.31% |
| 2018 Q4 | -52.53 Million EUR | 0.76% |
| 2018 Q2 | -80.07 Million EUR | 0.49% |
| 2018 FY | -52.53 Million EUR | 62.6% |
| 2018 Q1 | -80.47 Million EUR | 42.71% |
| 2018 Q3 | -52.93 Million EUR | 33.89% |
| 2017 Q3 | -140.87 Million EUR | -7.22% |
| 2017 Q2 | -131.38 Million EUR | 0.43% |
| 2017 Q1 | -131.95 Million EUR | -17.46% |
| 2017 FY | -140.46 Million EUR | -25.04% |
| 2017 Q4 | -140.46 Million EUR | 0.29% |
| 2016 Q4 | -112.34 Million EUR | 0.65% |
| 2016 FY | -112.34 Million EUR | -77.91% |
| 2016 Q2 | -66.82 Million EUR | 2.16% |
| 2016 Q3 | -113.07 Million EUR | -69.21% |
| 2016 Q1 | -68.3 Million EUR | -8.17% |
| 2015 Q4 | -63.14 Million EUR | 2.24% |
| 2015 Q1 | -33.58 Million EUR | -44.72% |
| 2015 FY | -63.14 Million EUR | -172.07% |
| 2015 Q2 | -32.17 Million EUR | 4.22% |
| 2015 Q3 | -64.58 Million EUR | -100.77% |
| 2014 Q2 | -17.89 Million EUR | 7.06% |
| 2014 Q3 | -24.59 Million EUR | -37.44% |
| 2014 Q1 | -19.25 Million EUR | 44.33% |
| 2014 FY | -23.2 Million EUR | 32.91% |
| 2014 Q4 | -23.2 Million EUR | 5.65% |
| 2013 Q1 | -83.79 Million EUR | -479.32% |
| 2013 Q3 | -35.92 Million EUR | 56.46% |
| 2013 FY | -34.59 Million EUR | -139.13% |
| 2013 Q4 | -34.59 Million EUR | 3.71% |
| 2013 Q2 | -82.49 Million EUR | 1.55% |
| 2012 Q3 | -27.3 Million EUR | 9.34% |
| 2012 FY | -14.46 Million EUR | -26.35% |
| 2012 Q4 | -14.46 Million EUR | 47.02% |
| 2012 Q2 | -30.11 Million EUR | 0.0% |
| 2011 Q4 | -11.44 Million EUR | 0.0% |
| 2011 Q2 | -22.81 Million EUR | 0.0% |
| 2011 FY | -11.44 Million EUR | 53.94% |
| 2010 Q2 | -27.16 Million EUR | 0.0% |
| 2010 FY | -24.85 Million EUR | -75.21% |
| 2010 Q4 | -24.85 Million EUR | 0.0% |
| 2009 Q4 | -14.18 Million EUR | 0.0% |
| 2009 FY | -14.18 Million EUR | 20.63% |
| 2008 FY | -17.87 Million EUR | 25.42% |
| 2007 FY | -23.96 Million EUR | -416.33% |
| 2006 FY | 7.57 Million EUR | -63.71% |
| 2005 FY | 20.87 Million EUR | 9.48% |
| 2004 FY | 19.06 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Roche Holding AG | 25.4 Billion CHF | 100.191% |
| Roche Holding AG | 25.4 Billion CHF | 100.191% |